参考文献/References:
[1] Rowley AH,Pink AJ,Reindel R,et al.A study of cardiovascular miRNA biomarkers for Kawasaki disease[J].Pediatr Infect Dis J,2014,33(12):1296-1299.
[2] Matsunaga A,Harita Y,Shibagaki Y,et al.Identification of 4-trimethylaminobutyraldehyde dehydrogenase(TMABADH)as a candidate serum autoantibody target for Kawasaki Disease[J].PLoS One,2015,10(5):e0128189.
[3] Davies S,Sutton N,Blackstock S,et al.Predicting IVIG resistance in UKKawasaki disease[J].Arch Dis Child,2015,100(4):366-368.
[4] Tijsen AJ,Pinto YM,Creemers EE.Circulating microRNAs as diagnostic biomarkers for cardiovascular diseases[J].Am J Physiol HeartCirc Physiol,2012,303(9):H1085-1095.
[5] 李 勤,王玉明,段 勇.miRNAs与心血管疾病[J].现代检验医学杂志,2014,29(2):22-25.
Li Q,Wang YM,Duan Y.miRNAs and cardiovascular diseases[J].Journal of Modern Laboratory Medicine,2014,29(2):22-25.
[6] Nakamura Y,Yashiro M,Uehara R,et al.Epidemiologic features of Kawasaki disease in Japan:results of the 2007-2008 nationwide survey[J].J Epidemiol,2010,20(4):302-307.
[7] Eleftheriou D,Levin M,Shingadia D,et al.Management of Kawasaki disease[J].Arch Dis Child,2014,99(1):74-83.
[8] 姜 波,王玉明,段 勇.MicroRNA的研究进展及其与肺癌的关系[J].现代检验医学杂志,2012,27(1):5-9.
Jiang B,Wang YM,Duan Y.Research progress of microRNA and its relationship with Lung Cacer[J].Journal of Modern Laboratory Medicine,2012,27(1):5-9.
[9] Shimizu C,Kim J,Stepanowsky P,et al.Differential expression of miR-145 in children with Kawasaki disease[J].PLoS One,2013,8(3):e58159.
[10] 褚茂平,周爱华,胡 晨,等.miR-130a和miR-125b在川崎病外周血细胞中的表达及意义[J].浙江医学,2015,37(5):357-362,388.
Chu MP,Zhou AH,Hu C,et al.Plasma miR-130a and miR-125b as biomarkers of coronary artery dilatation in Kawasaki disease[J].Zhejiang Medical Journal,2015,37(5):357-362,388.
[11] Cordes KR,Sheehy NT,White MP,et al.miR-145 and miR-143 regulate smooth muscle cell fate and plasticity[J].Nature,2009,460(7256):705-710.
[12] Gatsiou A,Boeckel JN,Randriamboavonjy V,et al.MicroRNAs in plateletbiogenesis and function:implications in vascular homeostasis and inflammation[J].Curr Vasc Pharmacol,2013,10(5):524-531.
[13] Xin M,Small EM,Sutherland LB,et al.MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury[J].Genes & Development,2009,23(18):2166-2178.
[14] Elia L,Quintavalle M,Zhang J,et al.The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice:correlates with human disease[J].Cell Death Differ,2009,16(12):1590-1598.
相似文献/References:
[1]靳剑芸,李启亮,宋文琪.血浆血栓弹力图与抗凝血酶Ⅲ检测对儿童川崎病诊断的应用价值[J].现代检验医学杂志,2017,32(05):130.[doi:10.3969/j.issn.1671-7414.2017.05.017]
JIN Jian-yun,LI Qi-liang,SONG Wen-qi.Correlation Discussion of Blood Plasma Thromboelastography
Values and Antithrombin III Level in Children's Kawasaki Disease[J].Journal of Modern Laboratory Medicine,2017,32(05):130.[doi:10.3969/j.issn.1671-7414.2017.05.017]
[2]刘丽莎,李喆倩,谈 诚,等.川崎病并发冠脉损伤患儿血清活化HUVECs NF-κB促使MMP-9 mRNA水平上调的实验研究[J].现代检验医学杂志,2018,33(01):131.[doi:10.3969/j.issn.1671-7414.2018.01.001]
LIU Li-sha,LI Zhe-qian,TAN Cheng,et al.Experimental Study on the Up-Regulation of NF- kappa B
and MMP-9 mRNA Level in HUVECs Stimulated by Serum from Children
with Coronary Artery Lesions of Kawasaki Disease[J].Journal of Modern Laboratory Medicine,2018,33(05):131.[doi:10.3969/j.issn.1671-7414.2018.01.001]
[3]李俏,张李钰,赵传梅,等.西安地区儿童免疫球蛋白无反应型川崎病危险因素分析及预测评分体系的建立[J].现代检验医学杂志,2019,34(01):5.[doi:10.3969/j.issn.1671-7414.2019.01.002]
LI Qiao,ZHANG Li-yu,ZHAO Chuan-mei,et al.Analysis of Risk Factors of Intravenous Immunoglobulin
in Children with Non-Responsive Kawasaki Disease in Xi’an Area
and Establishment of Its Predictive Scoring System[J].Journal of Modern Laboratory Medicine,2019,34(05):5.[doi:10.3969/j.issn.1671-7414.2019.01.002]
[4]张书婉,黄君华,吴文婧,等.外周血 NLR 与 PLR 对儿童完全型川崎病冠状动脉损伤的预测分析[J].现代检验医学杂志,2020,35(06):38.[doi:doi:10.3969/j.issn.1671-7414.2020.06.010]
ZHANG Shu-wan,HUANG Jun-hua,WU Wen-jing,et al.Prediction Analysis of NLR and PLR for the Development of Coronary ArteryLesions in Patients with Complete Kawasaki Disease[J].Journal of Modern Laboratory Medicine,2020,35(05):38.[doi:doi:10.3969/j.issn.1671-7414.2020.06.010]
[5]马飞艳,王 娟,樊 萍.川崎病患儿血清趋化素和缺血修饰清蛋白水平与冠状动脉损伤的相关性及在治疗中的应用价值[J].现代检验医学杂志,2021,36(03):72.[doi:10.3969/j.issn.1671-7414.2021.03.016]
MA Fei-yan,WANG Juan,FAN Ping.Relationship between the Levels of Chemokine and Ischemia-modified Albuminin Serum and Coronary Artery Injury in Children with Kawasaki Disease and the Application Value in the Treatment[J].Journal of Modern Laboratory Medicine,2021,36(05):72.[doi:10.3969/j.issn.1671-7414.2021.03.016]
[6]黄君华,崔自明,张书婉,等.完全性川崎病患儿血清 25-羟基维生素 D水平检测对预测 IVIG抵抗的价值研究[J].现代检验医学杂志,2022,37(01):28.[doi:10.3969/j.issn.1671-7414.2022.01.006]
HUANG Jun-hua,CUI Zi-ming,ZHANG Shu-wan,et al.Value of Serum 25-Hydroxyvitamin D Levels in the Prediction of Intravenous Immunoglobulin Resistance in Patients withComplete Kawasaki Disease[J].Journal of Modern Laboratory Medicine,2022,37(05):28.[doi:10.3969/j.issn.1671-7414.2022.01.006]
[7]张俊民,许爱平,赵利平,等.川崎病患儿血清酸性鞘磷脂酶、钙调神经磷酸酶水平和炎症因子表达的相关性以及与免疫球蛋白治疗效果的关系研究[J].现代检验医学杂志,2022,37(05):180.[doi:10.3969/j.issn.1671-7414.2022.05.036]
ZHANG Jun-min,XU Ai-ping,ZHAO Li-ping,et al.Correlation between Serum Acid Sphingomyelinase, Calcineurin Levels and Expression of Inflammatory Factors in Children with Kawasaki Disease and the Relationship with the Therapeutic Effect of Immunoglobulin[J].Journal of Modern Laboratory Medicine,2022,37(05):180.[doi:10.3969/j.issn.1671-7414.2022.05.036]
[8]李月悦a,唐 莉a,朱明跃b.川崎病患儿血清CTRP9 和sCD146 水平表达与冠状动脉损伤的相关性研究[J].现代检验医学杂志,2024,39(03):170.[doi:10.3969/j.issn.1671-7414.2024.03.029]
LI Yueyuea,TANG Lia,ZHU Mingyueb.Correlation between the Expression Levels of Serum CTRP9 and sCD146 and Coronary Artery Lesions in Children with Kawasaki Disease[J].Journal of Modern Laboratory Medicine,2024,39(05):170.[doi:10.3969/j.issn.1671-7414.2024.03.029]